Institutional Ownership Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS). We have compiled data on the 73 institutions that hold shares in the stock, with a total of 30.4 Million shares, which have been reported (via 13F filing form) to have a value of $146 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
6,943,654
shares
|
$33.3 Million
0.86% of portfolio
|
Q3 2021
Reduced 13.78%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
5,562,729
shares
|
$26.7 Million
0.08% of portfolio
|
Q3 2024
Reduced 6.74%
|
|
|
Samlyn Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
4,530,333
shares
|
$21.7 Million
0.39% of portfolio
|
Q3 2024
Reduced 26.01%
|
|
|
Adams Street Partners LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
3,275,616
shares
|
$15.7 Million
10.6% of portfolio
|
Q1 2018
Added 7.01%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,420,619
shares
|
$11.6 Million
0.0% of portfolio
|
Q3 2024
Added 46.66%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 13, 2024 Q3 2024 |
1,497,268
shares
|
$7.19 Million
1.16% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
563,009
shares
|
$2.7 Million
0.0% of portfolio
|
Q3 2024
Added 22.36%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
562,024
shares
|
$2.7 Million
0.0% of portfolio
|
Q2 2024
Added 7.47%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
500,000
shares
|
$2.4 Million
0.99% of portfolio
|
Q3 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
393,262
shares
|
$1.89 Million
0.0% of portfolio
|
Q3 2024
Added 5.89%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
390,000
shares
|
$1.87 Million
0.52% of portfolio
|
Q4 2022
Reduced 25.29%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
386,588
shares
|
$1.86 Million
0.0% of portfolio
|
Q3 2024
Reduced 31.45%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
376,121
shares
|
$1.81 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
331,360
shares
|
$1.59 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
323,211
shares
|
$1.55 Million
0.0% of portfolio
|
Q3 2024
Added 333.5%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
311,288
shares
|
$1.49 Million
0.0% of portfolio
|
Q3 2024
Added 52.15%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
218,962
shares
|
$1.05 Million
0.0% of portfolio
|
Q3 2024
Added 753.65%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
178,246
shares
|
$855,580
0.0% of portfolio
|
Q3 2024
Added 48.16%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 08, 2024 Q3 2024 |
137,031
shares
|
$657,748
0.0% of portfolio
|
Q3 2024
Added 64.66%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
127,332
shares
|
$611,193
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
127,300
shares
|
$611,040
0.02% of portfolio
|
Q2 2024
Reduced 43.25%
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
122,858
shares
|
$589,718
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Towerview LLC
|
Nov 06, 2024 Q3 2024 |
117,500
shares
|
$564,000
0.44% of portfolio
|
Q3 2024
Reduced 70.63%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
105,450
shares
|
$506,160
0.0% of portfolio
|
Q3 2024
Added 27.06%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
97,073
shares
|
$465,950
0.0% of portfolio
|
Q3 2024
Added 83.12%
|